Results 61 to 70 of about 5,106 (179)

Plasminflammation—An Emerging Pathway to Bradykinin Production

open access: yesFrontiers in Immunology, 2019
Plasminogen activation is essential for fibrinolysis—the breakdown of fibrin polymers in blood clots. Besides this important function, plasminogen activation participates in a wide variety of inflammatory conditions. One of these conditions is hereditary
Coen Maas
doaj   +1 more source

Tranexamic acid in the management of traumatic brain injury: a systematic review and meta-analysis with trial sequential analysis [PDF]

open access: yesEinstein (São Paulo)
Introduction Traumatic brain injury is a leading cause of death and disability. Tranexamic acid, an antifibrinolytic agent, holds the potential for managing intracranial hemorrhages secondary to traumatic brain injury.
Thiago Gebrin   +5 more
doaj   +1 more source

Successful Management of Acute Catastrophic Juvenile Vaginal Bleeding in Glanzmann’s Thromboasthenia by Uterine Tamponade: A Case Report and Review of The Literature

open access: yesCase Reports in Hematology, 2012
Glanzmann’s thromboasthenia (GT) is a rare platelet disorder, due to membrane defects involving glycoprotein GP IIb/IIIa complex. Symptoms appear in infancy with episodes of bruising, gingival bleeding, epistaxis, or at the time of menarche acute episode
Nazli Hossain   +2 more
doaj   +1 more source

Beyond lipids: Systemic effects of lipoprotein apheresis

open access: yes
Transfusion, Volume 66, Issue 3, Page 590-598, March 2026.
Menatalla Nadim, Yamac Akgun
wiley   +1 more source

Comparative study of topical vs. intravenous tranexamic acid regarding blood loss in total knee arthroplasty

open access: yesRevista Brasileira de Ortopedia
Objective: To compare topical vs. intravenous tranexamic acid (TA) in total knee arthroplasty regarding blood loss and transfusion., Methods: Ninety patients were randomized to receive TA intravenously (20 mg/kg in 100 mL of saline; group IV ...
Ari Zekcer   +4 more
doaj   +1 more source

Peri- and Postpartum Management of Patients With Factor XI Deficiency

open access: yesClinical and Applied Thrombosis/Hemostasis, 2019
Factor XI (FXI) deficiency is an uncommon autosomal disorder with variable bleeding phenotype, making peripartum management challenging. We describe our experience in pregnant women with FXI deficiency and identify strategies to minimize the use of ...
Gloria F. Gerber MD   +4 more
doaj   +1 more source

The Jehovah’s Witness obstetric patient – a literature review

open access: yesAnaesthesiology Intensive Therapy, 2019
The patient’s right to refuse blood transfusion must be honoured in case of its clear expression. Some special pharmacologic and/or surgical procedures can be useful in a Jehovah Witness (JW) parturient.
Aleksandra Rajewska   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy